This is a good find Vulcarum. The fact that Teva is launching it's smart inhaler now to the UK general market even without reimbursements like the US is offering is a very positive sign for Adherium's UK operation. Teva would have done it's home work first before making this decision. I don't see any mention of how they plan to integrate their product. Maybe keeping that info close to their chest.
Very interesting article, page-258
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.002(11.8%) |
Mkt cap ! $13.87M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.9¢ | 1.8¢ | $42.10K | 2.330M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000000 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 491829 | 4 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| ADR (ASX) Chart |